Effects of aging and liver disease on disposition of lorazepam
- 1 October 1978
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 24 (4), 411-419
- https://doi.org/10.1002/cpt1978244411
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium)Gastroenterology, 1978
- Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary ResultsThe Journal of Clinical Pharmacology, 1977
- Toxicity of high‐dose flurazepam in the elderlyClinical Pharmacology & Therapeutics, 1977
- Clinical pharmacokinetics of lorazepam; II. Intramuscular injectionClinical Pharmacology & Therapeutics, 1977
- Protein Binding and Kinetics of Drugs in Liver DiseasesClinical Pharmacokinetics, 1977
- Effects of liver disease on drug disposition in manBiochemical Pharmacology, 1976
- Clinical pharmacokinetics of lorazepamClinical Pharmacology & Therapeutics, 1976
- Normal Disposition of Oxazepam in Acute Viral Hepatitis and CirrhosisAnnals of Internal Medicine, 1976
- Absorption, Metabolism, and Excretion of Oxazepam and Its Succinate Half-EsterJournal of Pharmaceutical Sciences, 1964
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†JCI Insight, 1959